Elevated liver enzymes, often discovered incidentally during routine bloodwork, present a common yet complex issue in clinical practice. The challenge lies in identifying the underlying cause and managing it effectively.
Increased liver enzymes, specifically Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), indicate hepatocellular injury. However, these elevations can stem from a myriad of conditions, including viral hepatitis, alcohol-induced liver disease, non-alcoholic fatty liver disease (NAFLD), and drug-induced liver injury.
A comprehensive history and physical examination are crucial initial steps. They may reveal risk factors such as alcohol consumption, medication use, or signs of chronic liver disease. If the etiology remains unclear, serologic testing can help identify viral hepatitis or autoimmune liver disease. Imaging studies, especially ultrasound, can detect structural abnormalities or fatty infiltration. In some cases, liver biopsy may be necessary.
Management primarily involves addressing the underlying cause. For instance, alcohol abstinence is advised in alcohol-related liver disease, while weight loss and control of metabolic risk factors are key in NAFLD. Certain drug-induced liver injuries may require discontinuation of the offending agent. In viral hepatitis, antiviral therapy is the mainstay of treatment.
Regular follow-up with liver function tests is essential to monitor the response to treatment and detect any progression of the disease. In some cases, referral to a hepatologist may be necessary for further management.
In conclusion, the management of elevated liver enzymes necessitates a comprehensive, patient-centered approach. Understanding the various potential causes, employing a systematic diagnostic strategy, and tailoring management to the specific etiology can lead to successful patient outcomes.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation